Helius Medical Technologies, Inc. reported that as of June 16, 2025, following the approval of its stockholders on May 23, 2025, the number of shares available under the 2022 Equity Incentive Plan increased to 7.1 million shares after a public offering. This change follows a board decision made on April 22, 2025, to amend the Plan to add 20% of Fully Diluted Shares.